课题基金 / 基金详情

Investigating the Regulatory Roles of Histone Chaperones in Cellular Plasticity

Investigating the Regulatory Roles of Histone Chaperones in Cellular Plasticity
研究组蛋白伴侣在细胞可塑性中的调节作用
批准号:
10714076
负责人:
Sihem Cheloufi
金额:
$38.88万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-01 至 2028-07-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
项目总结 组蛋白伴侣蛋白是一种功能和结构都不同的蛋白质。它们在染色质中起着核心作用 DNA过程中通过与组蛋白结合促进核小体组装的组织和维持 复制、转录、重组和修复过程。此外,还进化出了一些组蛋白伴侣 不依赖于组蛋白结合的附加功能。因此,组蛋白伴侣对细胞是必不可少的 增殖和生物体发育。有趣的是,在一些细胞命运中绕过了这种致命的 改变范式揭示了组蛋白伴侣蛋白在细胞可塑性中的作用。例如,我们和其他人有 研究表明,染色质组装因子1(CAF-1)是一种参与复制的组蛋白伴侣复合体 依赖于核小体组装和异染色质调节,阻止细胞重新编程。更多 最近,我们证明了caf-1通过抑制表达来维持干细胞和祖细胞的谱系完整性。 分化基因的转录。在这种情况下,CAF-1控制染色质的可及性 家族特异性基因座的增强子/启动子元件,并防止转录因子的异常结合。在……里面 除了这些caf-1敏感位点外,我们还发现了其可及性受到干扰的异染色位点。 在CAF-1丢失时,尽管对细胞命运的影响未知。钙调素-1对小鼠局部色泽和眼球运动的影响 鉴于Caf-1以独立于序列的方式进行组装,异色基因座很有趣 DNA复制过程中的核小体。CAF-1对细胞命运的如此深远的影响是否与其 核小体组装功能或额外的非规范功能仍未被探索。此外,鉴于 随着组蛋白伴侣蛋白和相关组蛋白变体的不断增加,目前尚不清楚Caf-1是否 与其他组蛋白伴侣蛋白合作以维持血统的完整性。因此,功能和结构 在细胞命运的背景下,组蛋白伴侣网络作为一个整体的决定因素仍然是重要的开放的 问题。研究组蛋白谱系特定功能的分子机制 伴侣,我们将使用成熟的细胞命运改变范例与基因编辑/RNAi相结合, 多组学、生化和功能方法。具体地说,我们提出了以下两项研究 方向:(1)研究组蛋白伴侣敏感染色质的调控机制和功能 和,(2)询问组蛋白伴侣蛋白的结构-功能关系以及它们的结构域是如何 与控制细胞命运密切相关。在短期内,我们计划解剖表观基因组和结构 CAF-1的决定因素。从长远来看,我们计划将我们的分析扩展到其他组蛋白伴侣蛋白途径 以及它们如何与CAF-1合作控制细胞命运。如果成功,我们的研究将为设计做出贡献 操纵组蛋白伴侣通路以控制健康和疾病中细胞命运的策略。
英文摘要
PROJECT SUMMARY Histone chaperones are functionally and structurally diverse proteins. They play a central role in chromatin organization and maintenance by binding to histones and facilitating nucleosome assembly during DNA replication, transcription, recombination and repair processes. Moreover, some histone chaperones evolved additional functions independent of histone binding. Histone chaperones are thus essential for cellular proliferation and organismal development. Intriguingly, circumventing this lethality in a number of cell fate change paradigms revealed roles of histone chaperones in cellular plasticity. For example, we and others have shown that the chromatin assembly factor 1 (CAF-1), a histone chaperone complex involved in replication dependent nucleosome assembly and heterochromatin regulation, prevents cellular reprogramming. More recently, we demonstrated that CAF-1 maintains lineage integrity of stem and progenitor cells by repressing the transcription of differentiation genes. In this context, CAF-1 controls chromatin accessibility at enhancer/promoter elements of lineage specific loci and prevents aberrant binding of transcription factors. In addition to these CAF-1 sensitive sites, we also identified heterochromatic loci whose accessibility is perturbed upon CAF-1 loss, albeit with unknown effects on cell fate. The influence of CAF-1 on local euchromatic and heterochromatic loci is intriguing given that CAF-1 acts in a sequence independent manner to assemble nucleosomes during DNA replication. Whether such profound effects of CAF-1 on cell fate are linked to its nucleosome assembly function or additional non-canonical functions remain unexplored. Moreover, given the growing repertoire of histone chaperones and associated histone variants, it remains unclear whether CAF-1 cooperates with other histone chaperones to maintain lineage integrity. Therefore, the functional and structural determinants of the histone chaperone network as a whole in the context of cell fate remain important open questions. To investigate the molecular mechanisms underlying the lineage specifying functions of histone chaperones, we will use well established cell fate change paradigms in combination with gene editing/RNAi, multi-omics, biochemical and functional approaches. Specifically, we propose the following two research directions: (1) Investigate the regulatory mechanisms and function of histone chaperone sensitive chromatin sites and, (2) interrogate the structure-function relationships of histone chaperones and how their domains are intimately linked to control cell fate. In the short-term, we plan to dissect the epigenome and structural determinants of CAF-1. In the long-term we plan to extend our analysis to other histone chaperones pathways and how they cooperate with CAF-1 to control cell fate. If successful, our studies will contribute to design strategies for manipulating histone chaperone pathways to control cell fate in health and disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金